{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T06:11:23Z","timestamp":1793081483077,"version":"4.5.0"},"reference-count":32,"publisher":"American Diabetes Association","issue":"12","content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2004,12,1]]},"abstract":"<jats:p>OVE26 mice are a transgenic model of severe early-onset type 1 diabetes. These mice develop diabetes within the first weeks of life and can survive well over a year with no insulin treatment, and they maintain near normal body weight. To determine whether OVE26 mice provide a valuable model of chronic diabetic nephropathy (DN), OVE26 diabetic mice were compared with their nondiabetic littermates for functional and structural characteristics of DN. OVE26 mice exhibited pronounced polyuria and significant albuminuria by 2 months of age (305 \u03bcg\/24 h in OVE26 vs. 20 \u03bcg\/24 h in controls). Albumin excretion rate increased progressively with age and exceeded 15,000 \u03bcg\/24 h at 9 months of age. The profound loss of albumin led to hypoalbuminemia in some diabetic animals. Albuminuria coincided with an elevation in blood pressure as measured by tail cuff. The glomerular filtration rate (GFR) in OVE26 mice measured using fluorescein isothiocynate inulin clearance demonstrated that GFR increased significantly from 2 to 3 months of age and then decreased significantly from 5 to 9 months. GFR in 9-month-old diabetic mice was significantly lower than that of 9-month-old control mice. The decline in GFR coincided with a significant increase in renal vascular resistance. Structural studies showed an almost twofold increase in kidney weight between 2 and 5 months. Diabetic mice also showed progressively enlarged glomeruli and expanded mesangium with diffuse and nodular expansion of mesangial matrix. Tubulointerstitial fibrosis was also observed in these mice. Glomerular basement membrane was thickened in OVE26 mice. In summary, OVE26 mice demonstrate that most of the characteristics of human DN can be produced by chronic hyperglycemia in a murine model. This model will be useful for improved understanding and treatment of DN.<\/jats:p>","DOI":"10.2337\/diabetes.53.12.3248","type":"journal-article","created":{"date-parts":[[2007,3,6]],"date-time":"2007-03-06T19:04:22Z","timestamp":1173207862000},"page":"3248-3257","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":135,"title":["Development of Late-Stage Diabetic Nephropathy in OVE26 Diabetic Mice"],"prefix":"10.2337","volume":"53","author":[{"given":"Shirong","family":"Zheng","sequence":"first","affiliation":[{"name":"Department of Pediatrics, University of Louisville School of Medicine, Louisville, Kentucky"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William T.","family":"Noonan","sequence":"additional","affiliation":[{"name":"Department of Genome Science, University of Cincinnati College of Medicine, Cincinnati, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naira S.","family":"Metreveli","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Louisville School of Medicine, Louisville, Kentucky"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Coventry","sequence":"additional","affiliation":[{"name":"Department of Pathology, Kosair Children\u2019s Hospital, Louisville, Kentucky"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia M.","family":"Kralik","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Louisville School of Medicine, Louisville, Kentucky"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward C.","family":"Carlson","sequence":"additional","affiliation":[{"name":"Department of Anatomy and Cell Biology, University of North Dakota, Grand Forks, North Dakota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul N.","family":"Epstein","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Louisville School of Medicine, Louisville, Kentucky"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","reference":[{"key":"2022031208495050800_R1","doi-asserted-by":"crossref","unstructured":"Teutsch S, Newman J, Eggers P: The problem of diabetic renal failure in the United States: an overview. Am J Kidney Dis\u200813:11\u201313,1989","DOI":"10.1016\/S0272-6386(89)80106-4"},{"key":"2022031208495050800_R2","unstructured":"Cohen MP, Clements RS, Hud E, Cohen JA, Ziyadeh FN: Evolution of renal function abnormalities in the db\/db mouse that parallels the development of human diabetic nephropathy. Exp Nephrol\u20084:166\u2013171,1996"},{"key":"2022031208495050800_R3","doi-asserted-by":"crossref","unstructured":"Yotsumoto T, Naitoh T, Shikada K, Tanaka S: Effects of specific antagonists of angiotensin II receptors and captopril on diabetic nephropathy in mice. Jpn J Pharmacol\u200875:59\u201364,1997","DOI":"10.1016\/S0021-5198(19)31347-2"},{"key":"2022031208495050800_R4","doi-asserted-by":"crossref","unstructured":"Sharma K, McCue P, Dunn SR: Diabetic kidney disease in the db\/db mouse. Am J Physiol Renal Physiol\u2008284:F1138\u2013F1144,2003","DOI":"10.1152\/ajprenal.00315.2002"},{"key":"2022031208495050800_R5","unstructured":"Consortium on Diabetic Complications: Report of Animal Models of Diabetic Complications Consortium, 4 June 2003. Bethesda, MD, National Institutes of Health,2003"},{"key":"2022031208495050800_R6","doi-asserted-by":"crossref","unstructured":"Epstein PN, Overbeek PA, Means AR: Calmodulin-induced early-onset diabetes in transgenic mice. Cell\u200858:1067\u20131073,1989","DOI":"10.1016\/0092-8674(89)90505-9"},{"key":"2022031208495050800_R7","doi-asserted-by":"crossref","unstructured":"Motoike T, Loughna S, Perens E, Roman BL, Liao W, Chau TC, Richardson CD, Kawate T, Kuno J, Weinstein BM, Stainier DY, Sato TN: Universal GFP reporter for the study of vascular development. Genesis\u200828:75\u201381,2000","DOI":"10.1002\/1526-968X(200010)28:2<75::AID-GENE50>3.0.CO;2-S"},{"key":"2022031208495050800_R8","doi-asserted-by":"crossref","unstructured":"Epstein PN, Ribar TJ, Decker GL, Yaney G, Means AR: Elevated beta-cell calmodulin produces a unique insulin secretory defect in transgenic mice. Endocrinology\u2008130:1387\u20131393,1992","DOI":"10.1210\/endo.130.3.1371447"},{"key":"2022031208495050800_R9","doi-asserted-by":"crossref","unstructured":"Lorenz JN, Baird NR, Judd LM, Noonan WT, Andringa A, Doetschman T, Manning PA, Liu LH, Miller ML, Shull GE: Impaired renal NaCl absorption in mice lacking the ROMK potassium channel: a model for type II Bartter\u2019s syndrome. J Biol Chem\u2008277:37871\u201337880,2002","DOI":"10.1074\/jbc.M205627200"},{"key":"2022031208495050800_R10","doi-asserted-by":"crossref","unstructured":"Lorenz JN, Gruenstein E: A simple, nonradioactive method for evaluating single-nephron filtration rate using FITC-inulin. Am J Physiol\u2008276:F172\u2013F177,1999","DOI":"10.1152\/ajprenal.1999.276.1.F172"},{"key":"2022031208495050800_R11","doi-asserted-by":"crossref","unstructured":"Waugh WH, Beall PT: Simplified measurement of p-aminohippurate and other arylamines in plasma and urine. Kidney Int\u20085:429\u2013436,1974","DOI":"10.1038\/ki.1974.61"},{"key":"2022031208495050800_R12","doi-asserted-by":"crossref","unstructured":"Lorenz JN: A practical guide to evaluating cardiovascular, renal, and pulmonary function in mice. Am J Physiol Regul Integr Comp Physiol\u2008282:R1565\u2013R1582,2002","DOI":"10.1152\/ajpregu.00759.2001"},{"key":"2022031208495050800_R13","doi-asserted-by":"crossref","unstructured":"Hartner A, Eifert T, Haas CS, Tuysuz C, Hilgers KF, Reinhardt DP, Amann K: Characterization of the renal phenotype in a mouse model of Marfan syndrome. Virchows Arch\u2008445:382\u2013384,2004","DOI":"10.1007\/s00428-004-1081-6"},{"key":"2022031208495050800_R14","doi-asserted-by":"crossref","unstructured":"Sanden SK, Wiggins JE, Goyal M, Riggs LK, Wiggins RC: Evaluation of a thick and thin section method for estimation of podocyte number, glomerular volume, and glomerular volume per podocyte in rat kidney with Wilms\u2019 tumor-1 protein used as a podocyte nuclear marker. J Am Soc Nephrol\u200814:2484\u20132493,2003","DOI":"10.1097\/01.ASN.0000089829.45296.7C"},{"key":"2022031208495050800_R15","doi-asserted-by":"crossref","unstructured":"Chen S, Iglesias-de la Cruz MC, Jim B, Hong SW, Isono M, Ziyadeh FN: Reversibility of established diabetic glomerulopathy by anti-TGF-beta antibodies in db\/db mice. Biochem Biophys Res Commun\u2008300:16\u201322,2003","DOI":"10.1016\/S0006-291X(02)02708-0"},{"key":"2022031208495050800_R16","doi-asserted-by":"crossref","unstructured":"Ziyadeh FN, Hoffman BB, Han DC, Iglesias-de la Cruz MC, Hong SW, Isono M, Chen S, McGowan TA, Sharma K: Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db\/db diabetic mice. Proc Natl Acad Sci U S A\u200897:8015\u20138020,2000","DOI":"10.1073\/pnas.120055097"},{"key":"2022031208495050800_R17","doi-asserted-by":"crossref","unstructured":"Cohen MP, Sharma K, Jin Y, Hud E, Wu VY, Tomaszewski J, Ziyadeh FN: Prevention of diabetic nephropathy in db\/db mice with glycated albumin antagonists: a novel treatment strategy. J Clin Invest\u200895:2338\u20132345,1995","DOI":"10.1172\/JCI117926"},{"key":"2022031208495050800_R18","doi-asserted-by":"crossref","unstructured":"Craven PA, Melhem MF, Phillips SL, DeRubertis FR: Overexpression of Cu2+\/Zn2+ superoxide dismutase protects against early diabetic glomerular injury in transgenic mice. Diabetes\u200850:2114\u20132125,2001","DOI":"10.2337\/diabetes.50.9.2114"},{"key":"2022031208495050800_R19","unstructured":"Karnovsky MJ: A formaldehyde-glutaraldehyde fixitive for high osmololity for use in electron microscopy. J Cell Biol\u200835:137A\u2013138A,1965"},{"key":"2022031208495050800_R20","doi-asserted-by":"crossref","unstructured":"Carlson EC, Audette JL, Klevay LM, Nguyen H, Epstein PN: Ultrastructural and functional analyses of nephropathy in calmodulin-induced diabetic transgenic mice. Anat Rec\u2008247:9\u201319,1997","DOI":"10.1002\/(SICI)1097-0185(199701)247:1<9::AID-AR2>3.0.CO;2-W"},{"key":"2022031208495050800_R21","doi-asserted-by":"crossref","unstructured":"Carlson EC, Meezan E, Brendel K, Kenney MC: Ultrastructural analyses of control and enzyme-treated isolated renal basement membranes. Anat Rec\u2008200:421\u2013436,1981","DOI":"10.1002\/ar.1092000405"},{"key":"2022031208495050800_R22","doi-asserted-by":"crossref","unstructured":"Venable JH, Coggeshall R: A simplified lead stain for use in electron microscopy. J Cell Biol\u200825:407\u2013408,1965","DOI":"10.1083\/jcb.25.2.407"},{"key":"2022031208495050800_R23","doi-asserted-by":"crossref","unstructured":"Yang B, Ma T, Verkman AS: Erythrocyte water permeability and renal function in double knockout mice lacking aquaporin-1 and aquaporin-3. J Biol Chem\u2008276:624\u2013628,2001","DOI":"10.1074\/jbc.M008664200"},{"key":"2022031208495050800_R24","doi-asserted-by":"crossref","unstructured":"Takahashi N, Chernavvsky DR, Gomez RA, Igarashi P, Gitelman HJ, Smithies O: Uncompensated polyuria in a mouse model of Bartter\u2019s syndrome. Proc Natl Acad Sci U S A\u200897:5434\u20135439,2000","DOI":"10.1073\/pnas.090091297"},{"key":"2022031208495050800_R25","unstructured":"DeFronzo RA: Diabetic nephropathy. In Ellenberg & Rifkin\u2019s Diabetes Mellitus. Porte D, Sherwin RS, Baron A, Eds. New York, McGraw Hill,2004, p.723\u2013745"},{"key":"2022031208495050800_R26","doi-asserted-by":"crossref","unstructured":"Carlson EC, Audette JL, Veitenheimer NJ, Risan JA, Laturnus DI, Epstein PN: Ultrastructural morphometry of capillary basement membrane thickness in normal and transgenic diabetic mice. Anat Rec\u2008271:A:332\u2013A341,2003","DOI":"10.1002\/ar.a.10038"},{"key":"2022031208495050800_R27","doi-asserted-by":"crossref","unstructured":"Nobrega MA, Fleming S, Roman RJ, Shiozawa M, Schlick N, Lazar J, Jacob HJ: Initial characterization of a rat model of diabetic nephropathy. Diabetes\u200853:735\u2013742,2004","DOI":"10.2337\/diabetes.53.3.735"},{"key":"2022031208495050800_R28","unstructured":"Caramori MLA, Mauer M: Pathophysiology of renal complications. In Ellenberg & Rifkin\u2019s Diabetes Mellitus. Porte D, Sherwin RS, Baron A, Eds. New York, McGraw Hill,2004, p.697\u2013721"},{"key":"2022031208495050800_R29","doi-asserted-by":"crossref","unstructured":"Ziyadeh FN: The extracellular matrix in diabetic nephropathy. Am J Kidney Dis\u200822:736\u2013744,1993","DOI":"10.1016\/S0272-6386(12)80440-9"},{"key":"2022031208495050800_R30","doi-asserted-by":"crossref","unstructured":"Meyer MH, Meyer RA Jr, Gray RW, Irwin RL: Picric acid methods greatly overestimate serum creatinine in mice: more accurate results with high-performance liquid chromatography. Anal Biochem\u2008144:285\u2013290,1985","DOI":"10.1016\/0003-2697(85)90118-6"},{"key":"2022031208495050800_R31","doi-asserted-by":"crossref","unstructured":"Gross V, Schunck WH, Honeck H, Milia AF, Kargel E, Walther T, Bader M, Inagami T, Schneider W, Luft FC: Inhibition of pressure natriuresis in mice lacking the AT2 receptor. Kidney Int\u200857:191\u2013202,2000","DOI":"10.1046\/j.1523-1755.2000.00820.x"},{"key":"2022031208495050800_R32","doi-asserted-by":"crossref","unstructured":"Ma X, Sigmund CD, Hingtgen SD, Tian X, Davisson RL, Abboud FM, Chapleau MW: Ganglionic action of angiotensin contributes to sympathetic activity in renin-angiotensinogen transgenic mice. Hypertension\u200843:312\u2013316,2004","DOI":"10.1161\/01.HYP.0000111835.16662.43"}],"container-title":["Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.org\/diabetes\/diabetes\/article-pdf\/53\/12\/3248\/377324\/zdb01204003248.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article-pdf\/53\/12\/3248\/377324\/zdb01204003248.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T16:20:31Z","timestamp":1667406031000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article\/53\/12\/3248\/14441\/Development-of-Late-Stage-Diabetic-Nephropathy-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12,1]]},"references-count":32,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2004,12,1]]}},"URL":"https:\/\/doi.org\/10.2337\/diabetes.53.12.3248","relation":{},"ISSN":["0012-1797","1939-327X"],"issn-type":[{"value":"0012-1797","type":"print"},{"value":"1939-327X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,12,1]]}}}